DBV.PA
Price:
$0.66
Market Cap:
$71.08M
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents, and adults. The milk-induced company is also developing Viaskin Milk that is in Phase I/II clinical trial for the treatment of Immunoglobulin E (IgE) mediated cow's milk protein allergy (CMPA); Viaskin Egg, a pre-clinical stage product for the treatment of hen's egg allergy; and booster vaccine for Bordetella pertussis. Its other earlier stage resea...[Read more]
Industry
Biotechnology
IPO Date
2012-03-29
Stock Exchange
EURONEXT
Ticker
DBV.PA
According to DBV Technologies S.A.’s latest financial reports and current stock price. The company's current ROE is -104.46%. This represents a change of 227.08% compared to the average of -31.94% of the last 4 quarters.
The mean historical ROE of DBV Technologies S.A. over the last ten years is -69.95%. The current -104.46% ROE has changed 49.33% with respect to the historical average. Over the past ten years (40 quarters), DBV.PA's ROE was at its highest in in the September 2023 quarter at 27.15%. The ROE was at its lowest in in the September 2024 quarter at -56.34%.
Average
-69.95%
Median
-64.76%
Minimum
-136.93%
Maximum
-13.87%
Discovering the peaks and valleys of DBV Technologies S.A. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 240.01%
Maximum Annual ROE = -13.87%
Minimum Annual Increase = -56.48%
Minimum Annual ROE = -136.93%
Year | ROE | Change |
---|---|---|
2023 | -51.88% | 4.78% |
2022 | -49.51% | -49.75% |
2021 | -98.52% | 26.89% |
2020 | -77.65% | -13.26% |
2019 | -89.52% | -34.62% |
2018 | -136.93% | 20.45% |
2017 | -113.68% | 141.04% |
2016 | -47.16% | 240.01% |
2015 | -13.87% | -33.31% |
2014 | -20.80% | -56.48% |
The current ROE of DBV Technologies S.A. (DBV.PA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-66.64%
5-year avg
-73.42%
10-year avg
-69.95%
DBV Technologies S.A.’s ROE is less than Genfit S.A. (1.77%), greater than Innate Pharma S.A. (-84.39%), greater than Cellectis S.A. (-75.49%), greater than ERYTECH Pharma S.A. (-84.88%), less than Nanobiotix S.A. (283.43%),
Company | ROE | Market cap |
---|---|---|
1.77% | $175.76M | |
-84.39% | $157.29M | |
-75.49% | $124.86M | |
-84.88% | $48.66M | |
283.43% | $151.89M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like DBV Technologies S.A. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like DBV Technologies S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is DBV Technologies S.A.'s ROE?
How is the ROE calculated for DBV Technologies S.A. (DBV.PA)?
What is the highest ROE for DBV Technologies S.A. (DBV.PA)?
What is the 3-year average ROE for DBV Technologies S.A. (DBV.PA)?
What is the 5-year average ROE for DBV Technologies S.A. (DBV.PA)?
How does the current ROE for DBV Technologies S.A. (DBV.PA) compare to its historical average?